555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [xem ket qua xo so]
2 days ago · Stocks in spotlight: Brightcom, Alembic Pharma, Aurobindo, Lemon Tree among 15 to watch on August 18, 2025 Focus will also be on Gail (India), EMS, SPIC, JK Cement, MRC Agrotech, Capital India Finance
Aug 5, 2025 · Meanwhile, the companys board declared an interim dividend of Rs 4 per share for FY26, The company has fixed 8 August 2025, as the record date for the purpose of payment of interim dividend and the same will be paid on or before 21 August 2025. Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, …
5 days ago · The Exchange has sought clarification from Aurobindo Pharma Ltd on August 1, 2025, with reference to news appeared in 132d1b.555win5win.com dated August 1, 2025 quoting 'Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices'. The reply is awaited ...
Aug 6, 2025 · AUROPHARMA, BSE:524804- Keep track of all breaking news and updates on Aurobindo Pharma Ltd. from all sources in a single place.
Aug 4, 2025 · The Board of Directors of Aurobindo Pharma Limited at its meeting held on August 4, 2025, has approved the payment of interim dividend of 400% i.e. INR 4.00 per equity share of INR 1 each on the... -August 04, 2025 at 07:36 pm IST - MarketScreener India
Feb 5, 2025 · Get latest Aurobindo Pharma news and updates. Explore Aurobindo Pharma photos, videos and information on Times Now
21 hours ago · Aurobindo Pharma Share Price Today 19 Aug 2025: Track Aurobindo Pharma share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding ...
Aurobindo Pharma News: Read the latest Aurobindo Pharma news and updates. Explore Aurobindo Pharma photos, videos and information on ET Now.
2 days ago · Aurobindo Pharma - Read all the latest news headline updates on Aurobindo Pharma. Get all the Aurobindo Pharma breaking news updates, videos, photostories and more at Business Standard.
Aug 5, 2025 · This marks CuraTeQ's third EMA-approved biosimilar in 2025, reinforcing Aurobindo's focus on biosimilars with plans for 10 launches by 2030. Analysts predict a potential 20% upside for Aurobindo Pharma shares, with a consensus 'Buy' rating.
Jul 6, 2025 · This marks CuraTeQ's third EMA-approved biosimilar in 2025, reinforcing Aurobindo's focus on biosimilars with plans for 10 launches by 2030. Analysts predict a potential 20% upside for Aurobindo Pharma shares, with a consensus 'Buy' rating.
Aug 4, 2025 · The Board of Directors of Aurobindo Pharma Limited at its meeting held on August 4, 2025, has approved the payment of interim dividend of 400% i.e. INR 4.00 per equity share of INR 1 each on the...
Bài viết được đề xuất: